These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16425720)

  • 1. [Reasons for consulting related to skin-bleaching products used by 104 women in Brazzaville].
    Gathse A; Obengui ; Ibara JR
    Bull Soc Pathol Exot; 2005 Dec; 98(5):387-9. PubMed ID: 16425720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal.
    Mahé A; Ly F; Aymard G; Dangou JM
    Br J Dermatol; 2003 Mar; 148(3):493-500. PubMed ID: 12653741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widespread use of toxic skin lightening compounds: medical and psychosocial aspects.
    Ladizinski B; Mistry N; Kundu RV
    Dermatol Clin; 2011 Jan; 29(1):111-23. PubMed ID: 21095535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acne and skin bleaching in Lomé, Togo.
    Kombaté K; Mouhari-Toure A; Saka B; Akakpo AS; Maboudou A; Pitché P; Tchangaï-Walla K
    Int J Dermatol; 2012 Nov; 51 Suppl 1():27-9, 30-2. PubMed ID: 23210949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic contact dermatitis caused by a skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol.
    Suzuki K; Yagami A; Matsunaga K
    Contact Dermatitis; 2012 Jan; 66(1):51-2. PubMed ID: 22150905
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy.
    Charlín R; Barcaui CB; Kac BK; Soares DB; Rabello-Fonseca R; Azulay-Abulafia L
    Int J Dermatol; 2008 Jan; 47(1):19-23. PubMed ID: 18173595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cosmetic use of skin depigmentation products in Africa].
    Del Giudice P; Raynaud E; Mahé A
    Bull Soc Pathol Exot; 2003 Jan; 96(5):389-93. PubMed ID: 15015845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergic contact dermatitis caused by a skin-lightening agent, 5,5'-dipropylbiphenyl-2,2'-diol. A comment.
    Roberts DW; Aptula AO
    Contact Dermatitis; 2012 Jun; 66(6):357-9. PubMed ID: 22568852
    [No Abstract]   [Full Text] [Related]  

  • 10. [Symptomatic adrenal insufficiency secondary to the use of cutaneous topical steroids for skin-bleaching].
    Sène D; Huong-Boutin DL; Thiollet M; Barete S; Cacoub P; Piette JC
    Rev Med Interne; 2008 Dec; 29(12):1030-3. PubMed ID: 18586357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [List of compounds used as cosmetics and reported as containing skin-lightening ingredients that are dangerous for health].
    Groupe Thématique 'Peau Noire' de la Société Française de Dermatologie
    Ann Dermatol Venereol; 2011 May; 138(5):443-6. PubMed ID: 21570574
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroquinone-induced depigmentation: case report and review of the literature.
    Jow T; Hantash BM
    Dermatitis; 2014; 25(1):e1-5. PubMed ID: 24407054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dermatologic complications of the cosmetic use of bleaching agents in Bamako (Mali)].
    Mahé A; Kéita S; Bobin P
    Ann Dermatol Venereol; 1994; 121(2):142-6. PubMed ID: 7979025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous ochronosis and striae atrophicae following the use of bleaching creams.
    Bongiorno MR; Aricò M
    Int J Dermatol; 2005 Feb; 44(2):112-5. PubMed ID: 15689207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications of cosmetic skin bleaching in Africa].
    Morand JJ; Ly F; Lightburn E; Mahé A
    Med Trop (Mars); 2007 Dec; 67(6):627-34. PubMed ID: 18300529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of skin disorders associated with the use of bleaching cosmetics by Lome women].
    Pitche P; Afanou A; Amanga Y; Tchangaï-Walla K
    Sante; 1997; 7(3):161-4. PubMed ID: 9296805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous ochronosis.
    Martín RF; Sánchez JL; González A; Lugo-Somolinos A; Ruiz H
    P R Health Sci J; 1992 Apr; 11(1):23-6. PubMed ID: 1603931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of skin lightening creams. Survey in a UK general practice.
    Sidhu SK; Pau N; Sidhu JS; Oakeshott P
    BMJ; 2011 Mar; 342():d1326. PubMed ID: 21363856
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications of chronic use of skin lightening cosmetics.
    Olumide YM; Akinkugbe AO; Altraide D; Mohammed T; Ahamefule N; Ayanlowo S; Onyekonwu C; Essen N
    Int J Dermatol; 2008 Apr; 47(4):344-53. PubMed ID: 18377596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effect profile of common components of skin-lightening cosmetics.
    Prescrire Int; 2011 Sep; 20(119):212-3. PubMed ID: 21954517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.